Side effects
Zepbound Side Effects in the First Week on 2.5 mg
On the 2.5 mg starting dose, the label gives no day-by-day timing for Zepbound side effects in the first week. The drug peaks 8 to 72 hours after a shot.
Medically reviewed by Farnia Bahari, PharmD
Published 7 min read
Your first week on Zepbound is one 2.5 mg shot, and the label does not say which day after it side effects are worst (section 2.1). The drug peaks a median of 24 hours after the shot, anywhere from 8 to 72 hours, and slows your stomach most after the first dose (sections 12.2 and 12.3). In the trials, most nausea, vomiting and diarrhea came while the dose was being raised, and they decreased over time (section 6.1).

Key facts
- At every Zepbound dose, 56% of people had a stomach or bowel side effect, against 30% of those on placebo (Zepbound label, section 6.1).
- Severe stomach and bowel reactions were uncommon, 1.7 to 3.1% on Zepbound against 1% on placebo (Zepbound label, section 5.2).
- Between 1.9% and 4.3% of people stopped Zepbound over stomach or bowel side effects, against 0.5% on placebo (Zepbound label, section 6.1).
- Stomach pain that is severe and will not go away means stopping Zepbound and calling your healthcare provider right away (Zepbound Medication Guide).
Your first Zepbound shot and the days after it
The 2.5 mg dose is for starting only; the label does not approve it for maintenance (Zepbound prescribing information, section 2.1). Take your first shot on a Monday at 8 am and the drug peaks between Monday at 4 pm (8 hours) and Thursday at 8 am (72 hours) (section 12.3). The median falls on Tuesday at 8 am.
Tirzepatide also slows your stomach, and "the delay is largest after the first dose and this effect diminishes over time" (section 12.2). We found no published trial that reports on which day after a shot symptoms are worst.
The table is Pensday’s own model. It lines up the stomach symptoms you might expect with those label drug levels, and it is an inference to check against your own notes. The last row takes its easing from the label, where stomach side effects "decreased over time" (section 6.1).
| Time after the shot | Drug level (label) | What the model expects |
|---|---|---|
| First 24 hours | Rising; half reach the peak by 24 hours | Appetite drops; early queasiness is possible |
| Days 1–3 | At or near the peak, 8 to 72 hours | Nausea, early fullness and reflux most likely |
| Days 4–7 | Falling from the peak | Symptoms ease; appetite may return before the next shot |
| Weeks 2–4 on one dose | Each dose adds to what is left; steady by week 4 | Easing, as the label reports over time |
The GLP‑1 Plotter draws the last row, the climb to a steady level as weekly doses stack up. Its model has no absorption phase, so it shades the label’s 8 to 72 hour window after each shot instead of naming a peak time. To count the days from your last shot, log each one with its date and dose in Pensday.
How common each Zepbound side effect is
These rates come from two placebo-controlled weight-loss trials in which 2,519 adults took Zepbound for up to 72 weeks, so they cover far more than the first week (Zepbound prescribing information, section 6.1).
| Side effect | Zepbound 5–15 mg (%) | Placebo (%) |
|---|---|---|
| Nausea | 25–29 | 8 |
| Diarrhea | 19–23 | 8 |
| Constipation | 11–17 | 5 |
| Vomiting | 8–13 | 2 |
| Stomach pain | 9–10 | 5 |
| Indigestion | 9–10 | 4 |
| Injection site reactions | 6–8 | 2 |
Tiredness, allergic reactions, belching, hair loss, reflux, gas, bloating, dizziness and low blood pressure each affected between 1 and 7% of people on Zepbound (section 6.1). The injection site figure counts bruising, redness, itching, pain and rash, and a bruise or lump where you inject has its own causes.
At every dose, 56% of people reported at least one stomach or bowel side effect, against 30% on placebo. Between 1.9% and 4.3% stopped Zepbound because of them, against 0.5% on placebo. The majority of people who stopped for any side effect did so in the first few months, because of stomach and bowel effects (section 6.1).
How long they last, and why dose increases bring them back
Across the SURMOUNT-1 to -4 trials, stomach and bowel side effects were mostly mild to moderate and came mainly while the dose was going up, then diminished over time (Rubino, 2025).
Neither Zepbound source says how many days a single bout lasts. The nearest figures are how long nausea and diarrhea lasted in the semaglutide trials, a different drug. For Wegovy itself, see when Wegovy side effects start and how long they last.
Each Zepbound step adds 2.5 mg after at least 4 weeks at the current dose, an escalation the label sets "to reduce the risk of gastrointestinal adverse reactions" (section 2.1). Plan the weeks after each step with the Zepbound dose schedule in hand, or enter your start date in the dose titration planner to get the dates.
If a dose never settles, you can stay on it longer, since 4 weeks is a minimum. You can also stop at a lower maintenance dose, which the label says to consider when a maintenance dose is not tolerated (section 2.1). A short note of each bad day, counted from the shot, helps your prescriber choose between stepping up, waiting and settling lower.
What helps

The eating steps come from a multidisciplinary expert consensus on GLP‑1 stomach side effects (Gorgojo-Martínez, 2023), and a pooled analysis of the SURMOUNT trials suggests the same kind of steps for tirzepatide (Rubino, 2025).
- Eat smaller portions, slowly, and stop as soon as you feel full.
- Choose low-fat, easy-to-digest food, cooked in the oven, on a griddle or by boiling.
- Stay upright after meals, and avoid eating close to bedtime.
- Leave out alcohol and fizzy drinks while heaviness and reflux after meals are the problem.
After an unusually big meal, follow the steps for the hours after overeating on Ozempic. If diarrhea is the main problem, bland food, extra fluid and no sugar alcohols come first.
A 2025 consensus on nutrition for people on GLP‑1 drugs says "Hydration with > 2 L of fluid intake per day is necessary" (Sievenpiper et al., 2025). The Zepbound label warns that fluid lost to nausea, vomiting or diarrhea can injure the kidneys (section 5.3). Enter your weight in the water intake calculator for a daily fluid target.
Feeling full tends to cut how much people drink, which can lead to constipation (Gorgojo-Martínez, 2023). Drink generous amounts of water, move more and get enough fiber; set a daily target with the fiber calculator and build up to it.
When to call about Zepbound side effects
The Zepbound Medication Guide names these signs and what to do about each (Zepbound Medication Guide).
| What you notice | What to do | Why it matters |
|---|---|---|
| Severe stomach pain that will not go away, sometimes felt through to the back | Stop Zepbound; call your healthcare provider right away | Possible pancreatitis |
| Upper stomach pain, fever, yellow skin or eyes, or clay-colored stools | Tell your healthcare provider right away | Possible gallbladder problem |
| Nausea, vomiting or diarrhea that does not go away | Tell your healthcare provider right away | Fluid loss can harm the kidneys |
| Swelling of the face, lips, tongue or throat, or trouble breathing or swallowing | Stop Zepbound; get medical help right away | Serious allergic reaction |
Signs that you are losing too much fluid include extreme thirst or a dry mouth, urinating less than usual, dark urine, and feeling tired, dizzy or lightheaded (NIDDK, symptoms and causes of diarrhea). For anything else, tell your healthcare provider about stomach problems that are severe or will not go away, as the Medication Guide asks.
Choosing your shot day

Zepbound can go in at any time of day, with or without meals (section 2.4), so the day you choose decides where the 8 to 72 hour window falls in your week. To move the day, keep the two doses at least 3 days (72 hours) apart (section 2.3).
Questions
Frequently asked questions
Can I take anti-nausea medicine with Zepbound?
Possibly. The GLP‑1 consensus says to consider anti-nausea or prokinetic medicine when nausea or vomiting persists despite the eating changes (Gorgojo-Martínez, 2023). Ask which one first, because Zepbound "has the potential to impact the absorption" of medicines taken by mouth (Zepbound label, section 7.2).
Is it normal to have no stomach side effects on Zepbound?
Yes. In the label’s trials, 56% of people taking Zepbound reported a stomach or bowel side effect, which leaves 44% who did not (Zepbound label, section 6.1).
Does having side effects mean Zepbound is working better?
Not by much. In a pooled analysis of the SURMOUNT-1 to -4 trials, weight reduction on tirzepatide was similar whether people reported no nausea, nausea alone, or any nausea, vomiting or diarrhea. The authors saw only a trend toward about 2% more weight reduction in people with those symptoms (Rubino, 2025).
Does Zepbound cause headaches?
Headache is not among the reactions in the Zepbound label’s trial table, which lists every side effect seen in at least 2% of people and more often than on placebo (Zepbound label, section 6.1). It is on the Wegovy label, at 14% on semaglutide 2.4 mg against 10% on placebo (Wegovy prescribing information, section 6.1). With insulin or a sulfonylurea, the Zepbound Medication Guide lists headache among the signs of low blood sugar.
Sources
- Zepbound (tirzepatide) injection, prescribing information and Medication Guide. Eli Lilly and Company, 2026.
- Wegovy (semaglutide) injection and tablets, prescribing information and Medication Guide. Novo Nordisk, 2026.
- Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials. Diabetes, Obesity and Metabolism, 2025.
- Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP‑1 receptor agonists: a multidisciplinary expert consensus. Journal of Clinical Medicine, 2023.
- Nutritional and lifestyle supportive care recommendations for management of obesity with GLP‑1-based therapies: an expert consensus statement using a modified Delphi approach. Obesity Pillars, 2025.
- Symptoms and causes of diarrhea. National Institute of Diabetes and Digestive and Kidney Diseases, 2024.




